EG24019A - Optimised formulation of tobramycin for aerosolization - Google Patents

Optimised formulation of tobramycin for aerosolization

Info

Publication number: EG24019A
Authority: EG; Egypt
Prior art keywords: aerosolization; tobramycin; formulation; optimised; optimised formulation
Prior art date: 2001-07-02

Application number

EG2002060744A

Other languages

English (en)

Inventor

Chiara Malvolti

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2002-06-29

Publication date

2008-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8177921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24019(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-06-29 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2008-03-25 Application granted granted Critical

2008-03-25 Publication of EG24019A publication Critical patent/EG24019A/xx

Links

238000009472 formulation Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
238000012387 aerosolization Methods 0.000 title abstract 2
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 title abstract 2
229960000707 tobramycin Drugs 0.000 title abstract 2
201000003883 Cystic fibrosis Diseases 0.000 abstract 1
208000019693 Lung disease Diseases 0.000 abstract 1
241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000644 isotonic solution Substances 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EG2002060744A 2001-07-02 2002-06-29 Optimised formulation of tobramycin for aerosolization EG24019A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01116071A EP1273292B1 (de)	2001-07-02	2001-07-02	Optimierte Tobramycin-Formulierung zur Aerosolbildung

Publications (1)

Publication Number	Publication Date
EG24019A true EG24019A (en)	2008-03-25

Family

ID=8177921

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG2002060744A EG24019A (en)	2001-07-02	2002-06-29	Optimised formulation of tobramycin for aerosolization

Country Status (26)

Country	Link
US (5)	US6987094B2 (de)
EP (1)	EP1273292B1 (de)
JP (1)	JP4262086B2 (de)
KR (1)	KR100910888B1 (de)
CN (1)	CN1234346C (de)
AT (1)	ATE267591T1 (de)
AU (1)	AU2002319226B2 (de)
BG (1)	BG66328B1 (de)
BR (1)	BRPI0211320B8 (de)
CA (1)	CA2452638C (de)
CZ (1)	CZ299348B6 (de)
DE (1)	DE60103527T2 (de)
DK (1)	DK1273292T3 (de)
EA (1)	EA006068B1 (de)
EE (1)	EE05392B1 (de)
EG (1)	EG24019A (de)
ES (1)	ES2222294T3 (de)
HU (1)	HU230807B1 (de)
PL (1)	PL202598B1 (de)
PT (1)	PT1273292E (de)
SI (1)	SI1273292T1 (de)
SK (1)	SK285806B6 (de)
TN (1)	TNSN03149A1 (de)
TR (1)	TR200401980T4 (de)
WO (1)	WO2003004005A1 (de)
ZA (1)	ZA200400026B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW465235B (en)	1998-09-17	2001-11-21	United Video Properties Inc	Electronic program guide with digital storage
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1317720B1 (it) *	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
ES2222294T3 (es) *	2001-07-02	2005-02-01	Chiesi Farmaceutici S.P.A.	Formulacion optimizada de tobramicina para administracion en forma de aerosol.
TWI324518B (en)	2001-12-19	2010-05-11	Nektar Therapeutics	Pulmonary delivery of aminoglycosides
ME00077B (me) *	2002-03-01	2010-06-10	Chiesi Farm Spa	Formoterol najfiniji preparat
EP1673074B1 (de) *	2003-10-15	2007-01-03	PARI GmbH Spezialisten für effektive Inhalation	Flüssige zubereitung enthaltend tobramycin
US8442280B2 (en) *	2004-01-21	2013-05-14	Edda Technology, Inc.	Method and system for intelligent qualitative and quantitative analysis of digital radiography softcopy reading
ES2392389T3 (es)	2004-05-17	2012-12-10	Gilead Sciences, Inc.	Combinación de fosfomicina/aminoglucósido aerosolizada para el tratamiento de las infecciones respiratorias bacterianas
US8546423B2 (en) *	2005-05-18	2013-10-01	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) *	2005-05-18	2010-11-23	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
AU2006297289B2 (en)	2005-09-29	2013-03-21	Novartis Ag	Antibiotic formulations, unit doses, kits, and methods
US20090246146A1 (en) *	2008-01-25	2009-10-01	Botond Banfi	Halides in the treatment of pathogenic infection
AU2009302478B2 (en) *	2008-10-07	2015-09-03	Horizon Orphan Llc	Aerosol fluoroquinolone formulations for improved pharmacokinetics
CN102325532B (zh) *	2008-10-07	2015-06-17	Mpex医药有限公司	用于减轻肺部炎症的左氧氟沙星吸入剂
JP5960434B2 (ja) *	2009-02-18	2016-08-02	アラダイムコーポレーション	肺送達のためのｐＨ調節された製剤
LT2473170T (lt)	2009-09-04	2019-10-10	Horizon Orphan Llc	Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
EP2388008A1 (de)	2010-05-14	2011-11-23	Combino Pharm, S.L.	Stabile, konservierungsmittelfreie, wässrige Formulierung zur Verabreichung durch Aerosolisierung enthaltend Tobramycin
MX336260B (es)	2010-07-12	2016-01-13	Xellia Pharmaceuticals Aps	Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina.
US9271993B2 (en) *	2010-09-13	2016-03-01	University Of Zurich	Treatment of bacterial infectious diseases
US10105356B2 (en)	2011-01-31	2018-10-23	Avalyn Pharma Inc.	Aerosol pirfenidone and pyridone analog compounds and uses thereof
HUE058753T2 (hu) *	2011-01-31	2022-09-28	Avalyn Pharma Inc	Aeroszol formájú pirfenidon- és piridon-analóg vegyületek és alkalmazásaik
EP2567691B1 (de)	2011-09-12	2014-12-24	Meiji Seika Pharma Co., Ltd.	Wässrige Zusammensetzungen mit Arbekazin
GB201208080D0 (en)	2012-05-09	2012-06-20	Norton Healthcare Ltd	Tobramycin formulation
US12226407B2 (en)	2012-07-24	2025-02-18	Avalyn Pharma Inc.	Aerosol pirfenidone and pyridone analog compounds and uses thereof
CN105534961B (zh) *	2015-12-30	2019-06-04	孙红娟	妥布霉素吸入溶液及其制备方法
CN105616345B (zh) *	2016-03-01	2018-08-21	上海方予健康医药科技有限公司	一种妥布霉素吸入组合物及其制备方法和用途
EP3551191A4 (de) *	2016-12-09	2020-09-09	EnBiotix, Inc.	Aminoglykosid-potenzierung zur behandlung von pulmonaler bakterieller infektion
CN108014099B (zh) *	2017-12-15	2019-03-01	武汉兴华智慧医药科技有限公司	一种吸入用妥布霉素溶液及其制备方法
GB2565941A (en) *	2018-11-27	2019-02-27	Norton Healthcare Ltd	A process for preparing a formulation
CN113018443B (zh) *	2019-12-27	2022-09-13	海南斯达制药有限公司	治疗呼吸系统疾病的药物组合物及其制备方法
CN113952320B (zh) *	2021-09-18	2022-03-18	健康元药业集团股份有限公司	一种包含妥布霉素吸入溶液的药物组件及其用途

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3361306A (en)	1966-03-31	1968-01-02	Merck & Co Inc	Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en)	1969-12-10	1971-11-23	Schering Corp	Aerosol inhaler with flip-up nozzle
MX3864E (es)	1975-05-27	1981-08-26	Syntex Corp	Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4185100A (en)	1976-05-13	1980-01-22	Johnson & Johnson	Topical anti-inflammatory drug therapy
US4499108A (en)	1983-06-08	1985-02-12	Schering Corporation	Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en)	1983-12-24	1984-02-01	Tanabe Seiyaku Co	Carbostyril derivatives
IT1196142B (it)	1984-06-11	1988-11-10	Sicor Spa	Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en)	1985-01-03	1986-04-22	David Rubin	Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en)	1985-05-22	1993-03-09	Liposome Technology, Inc.	Corticosteroid inhalation treatment method
GB8828477D0 (en)	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
US5225183A (en)	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
US5006343A (en) *	1988-12-29	1991-04-09	Benson Bradley J	Pulmonary administration of pharmaceutically active substances
IL97065A (en)	1990-02-02	1994-01-25	Fisons Plc	Repellent preparations for aerosol
EP0563048A1 (de)	1990-12-19	1993-10-06	Smithkline Beecham Corporation	Aerosolformulierungen
US6006745A (en)	1990-12-21	1999-12-28	Minnesota Mining And Manufacturing Company	Device for delivering an aerosol
US5190029A (en)	1991-02-14	1993-03-02	Virginia Commonwealth University	Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en)	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
KR100229975B1 (ko)	1991-05-21	1999-11-15	스티븐 에프. 웨인스톡	에어로졸 흡입장치
HU216998B (hu)	1991-08-29	1999-11-29	Broncho-Air Medizintechnik Ag.	Orvosi készülék aeroszóladagok inhalálásához
IL103238A (en)	1991-09-25	1995-07-31	Fisons Plc	Pressurised aerosol compositions
IL104068A (en)	1991-12-12	1998-10-30	Glaxo Group Ltd	Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
DK0717987T3 (da)	1991-12-18	2001-11-12	Minnesota Mining & Mfg	Suspension-aerosol-formuleringer
DE4230876A1 (de)	1992-03-17	1993-09-23	Asta Medica Ag	Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
ES2129117T3 (es)	1992-12-09	1999-06-01	Boehringer Ingelheim Pharma	Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
SE9203743D0 (sv)	1992-12-11	1992-12-11	Astra Ab	Efficient use
WO1994014490A1 (de)	1992-12-23	1994-07-07	Bernhard Hugemann	Verfestigter arzneistoffvorrat für die mechanische erzeugung inhalierbarer wirkstoffpartikel
KR100321649B1 (ko)	1993-03-17	2002-07-22	미네소타 마이닝 앤드 매뉴팩춰링 캄파니	에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
DE69405719T2 (de)	1993-03-17	1998-01-15	Minnesota Mining & Mfg	Aerosolzubereitung, enthaltend ein aus einem diol-disäure-derivat abgeleitetes dispergiermittel
US6596260B1 (en)	1993-08-27	2003-07-22	Novartis Corporation	Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
EP0735884B1 (de)	1993-12-20	2000-04-26	Minnesota Mining And Manufacturing Company	Flunisolide aerosolformulierungen
US5508269A (en) *	1994-10-19	1996-04-16	Pathogenesis Corporation	Aminoglycoside formulation for aerosolization
GB9425160D0 (en)	1994-12-10	1995-02-08	Glaxo Group Ltd	Medicaments
JP4155594B2 (ja)	1994-12-22	2008-09-24	アストラゼネカ・アクチエボラーグ	エアゾール製剤
GB9426252D0 (en)	1994-12-24	1995-02-22	Glaxo Group Ltd	Pharmaceutical composition
DE4446891A1 (de)	1994-12-27	1996-07-04	Falk Pharma Gmbh	Stabile wäßrige Budesonid-Lösung
US5653961A (en)	1995-03-31	1997-08-05	Minnesota Mining And Manufacturing Company	Butixocort aerosol formulations in hydrofluorocarbon propellant
MX9707862A (es)	1995-04-14	1997-11-29	Glaxo Wellcome Inc	Inhalador de dosis medida para el propionato de fluticasona.
DE69622166T2 (de)	1995-04-14	2003-04-03	Smithkline Beecham Corp., Philadelphia	Dosierinhalator für albuterol
EP1366777B1 (de)	1995-04-14	2005-06-15	SmithKline Beecham Corporation	Dosierinhalator für Salmeterol
CA2218179A1 (en)	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Metered dose inhaler for beclomethasone dipropionate
GB9612297D0 (en)	1996-06-11	1996-08-14	Minnesota Mining & Mfg	Medicinal aerosol formulations
JP2000514085A (ja)	1996-07-08	2000-10-24	ローヌ―プーラン・ロウラー・リミテッド	医薬シクロスポリンａエーロゾル溶液処方物
AU3811897A (en)	1996-07-24	1998-02-10	Oglios Therapeutics, Inc.	Antisense oligonucleotides as antibacterial agents
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
GB9620187D0 (en)	1996-09-27	1996-11-13	Minnesota Mining & Mfg	Medicinal aerosol formulations
US6413496B1 (en)	1996-12-04	2002-07-02	Biogland Ireland (R&D) Limited	Pharmaceutical compositions and devices for their administration
WO1998024420A1 (en)	1996-12-04	1998-06-11	Bioglan Ireland (R & D) Limited	Pharmaceutical compositions and devices for their administration
US6461591B1 (en)	1997-02-05	2002-10-08	Jago Research Ag	Medical aerosol formulations
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US5891419A (en)	1997-04-21	1999-04-06	Aeropharm Technology Limited	Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
GB2326334A (en)	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
BR7702049U (pt)	1997-09-05	1999-09-14	Chiesi Farma Spa	Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
US5954047A (en)	1997-10-17	1999-09-21	Systemic Pulmonary Development, Ltd.	Methods and apparatus for delivering aerosolized medication
US6045784A (en)	1998-05-07	2000-04-04	The Procter & Gamble Company	Aerosol package compositions containing fluorinated hydrocarbon propellants
SE9802073D0 (sv)	1998-06-11	1998-06-11	Astra Ab	New use
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en)	1998-06-26	2001-06-05	Elan Corporation Plc	Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
DE19847969A1 (de)	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Lagerfähig flüssige Formulierung mit Formoterol
CN1150895C (zh)	1998-11-13	2004-05-26	杰格研究股份公司	用于吸入给药的干粉
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1303788B1 (it)	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
US6004537A (en)	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en)	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6315985B1 (en)	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it)	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
EE05167B1 (et)	2000-05-22	2009-06-15	Chiesi Farmaceutici S.P.A.	Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
ES2222294T3 (es) *	2001-07-02	2005-02-01	Chiesi Farmaceutici S.P.A.	Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340492A1 (de)	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
EP1415647A1 (de)	2002-10-23	2004-05-06	CHIESI FARMACEUTICI S.p.A.	Langwirkende beta-2-Agonisten in ultrafeiner Formulierung
ME00077B (me)	2002-03-01	2010-06-10	Chiesi Farm Spa	Formoterol najfiniji preparat
US20050083693A1 (en) *	2003-10-21	2005-04-21	Timothy Garrett	Flag illumination fixture

2001
- 2001-07-02 ES ES01116071T patent/ES2222294T3/es not_active Expired - Lifetime
- 2001-07-02 DE DE60103527T patent/DE60103527T2/de not_active Expired - Lifetime
- 2001-07-02 DK DK01116071T patent/DK1273292T3/da active
- 2001-07-02 TR TR2004/01980T patent/TR200401980T4/xx unknown
- 2001-07-02 AT AT01116071T patent/ATE267591T1/de active
- 2001-07-02 SI SI200130154T patent/SI1273292T1/xx unknown
- 2001-07-02 PT PT01116071T patent/PT1273292E/pt unknown
- 2001-07-02 EP EP01116071A patent/EP1273292B1/de not_active Expired - Lifetime
2002
- 2002-06-14 BR BRPI0211320A patent/BRPI0211320B8/pt not_active IP Right Cessation
- 2002-06-14 KR KR1020037017141A patent/KR100910888B1/ko not_active Expired - Lifetime
- 2002-06-14 US US10/482,224 patent/US6987094B2/en not_active Expired - Lifetime
- 2002-06-14 AU AU2002319226A patent/AU2002319226B2/en not_active Expired
- 2002-06-14 CN CNB028143140A patent/CN1234346C/zh not_active Expired - Lifetime
- 2002-06-14 SK SK1643-2003A patent/SK285806B6/sk not_active IP Right Cessation
- 2002-06-14 JP JP2003510016A patent/JP4262086B2/ja not_active Expired - Lifetime
- 2002-06-14 CA CA2452638A patent/CA2452638C/en not_active Expired - Lifetime
- 2002-06-14 WO PCT/EP2002/006544 patent/WO2003004005A1/en not_active Ceased
- 2002-06-14 EE EEP200400050A patent/EE05392B1/xx unknown
- 2002-06-14 EA EA200301305A patent/EA006068B1/ru active Protection Beyond IP Right Term
- 2002-06-14 CZ CZ20033580A patent/CZ299348B6/cs not_active IP Right Cessation
- 2002-06-14 HU HU0400387A patent/HU230807B1/hu unknown
- 2002-06-14 PL PL367139A patent/PL202598B1/pl unknown
- 2002-06-29 EG EG2002060744A patent/EG24019A/xx active
2003
- 2003-07-08 TN TNPCT/EP2002/006544A patent/TNSN03149A1/en unknown
- 2003-12-19 BG BG108475A patent/BG66328B1/bg unknown
2004
- 2004-01-05 ZA ZA2004/00026A patent/ZA200400026B/en unknown
2005
- 2005-03-18 US US11/083,139 patent/US7696178B2/en not_active Expired - Lifetime
2009
- 2009-12-18 US US12/642,336 patent/US7939502B2/en not_active Expired - Fee Related
2011
- 2011-05-06 US US13/102,378 patent/US8168598B2/en not_active Expired - Fee Related
2012
- 2012-03-26 US US13/429,624 patent/US20120184502A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0211320B8 (pt)	2021-05-25
PT1273292E (pt)	2004-10-29
EA200301305A1 (ru)	2004-06-24
HU230807B1 (hu)	2018-06-28
BG108475A (en)	2005-02-28
EA006068B1 (ru)	2005-08-25
JP4262086B2 (ja)	2009-05-13
PL367139A1 (en)	2005-02-21
KR20040018403A (ko)	2004-03-03
EE200400050A (et)	2004-04-15
CZ20033580A3 (cs)	2004-10-13
EE05392B1 (et)	2011-04-15
CA2452638A1 (en)	2003-01-16
DE60103527D1 (de)	2004-07-01
US7939502B2 (en)	2011-05-10
US7696178B2 (en)	2010-04-13
US8168598B2 (en)	2012-05-01
TNSN03149A1 (en)	2005-12-23
US6987094B2 (en)	2006-01-17
US20100098642A1 (en)	2010-04-22
US20120184502A1 (en)	2012-07-19
ES2222294T3 (es)	2005-02-01
AU2002319226B2 (en)	2006-07-06
ZA200400026B (en)	2005-03-30
CZ299348B6 (cs)	2008-06-25
HUP0400387A2 (hu)	2004-09-28
DK1273292T3 (da)	2004-10-04
BG66328B1 (bg)	2013-06-28
US20050163722A1 (en)	2005-07-28
EP1273292B1 (de)	2004-05-26
PL202598B1 (pl)	2009-07-31
US20040186064A1 (en)	2004-09-23
US20110212912A1 (en)	2011-09-01
EP1273292A1 (de)	2003-01-08
SK285806B6 (sk)	2007-08-02
DE60103527T2 (de)	2005-06-16
JP2004535454A (ja)	2004-11-25
ATE267591T1 (de)	2004-06-15
WO2003004005A1 (en)	2003-01-16
TR200401980T4 (tr)	2004-09-21
CN1234346C (zh)	2006-01-04
HK1068784A1 (en)	2005-05-06
CN1529589A (zh)	2004-09-15
BRPI0211320B1 (pt)	2015-08-18
KR100910888B1 (ko)	2009-08-05
BR0211320A (pt)	2004-09-28
CA2452638C (en)	2010-10-05
SI1273292T1 (en)	2004-12-31
SK16432003A3 (sk)	2004-06-08

Publication	Publication Date	Title
SI1273292T1 (en)	2004-12-31	Optimised formulation of tobramycin for aerosolization
PT1997478E (pt)	2013-12-10	Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
MXPA04005865A (es)	2004-09-13	Suministro de aminoglucosidos a los pulmones.
WO2002054868A3 (en)	2003-03-27	Pulmonary delivery of polyene antifungal agents
WO2001089496A3 (en)	2002-04-25	Compositions and methods for treating otic, ophthalmic and nasal infections comprising quinolone antibiotics
ES2136883T3 (es)	1999-12-01	Nueva formulacion mejorada de aminoglucosido para administracion en forma de aerosol.
BR0012750A (pt)	2002-04-02	Agente de limpeza para superfìcies cerâmicas vìtreas
LU91851I2 (fr)	2011-10-03	Aztréonam, pas en composition avec l'arginine, ou un sel pharmaceutiquement acceptable de l'aztréonam autre qu'un sel d'origine en particulier l'aztréonam lysine
NZ631469A (en)	2016-06-24	Aerosol fluoroquinolone formulations for improved pharmacokinetics
MX2010012452A (es)	2011-03-15	Suministro pulmonar de una fluoro-quinolona.
TW200612971A (en)	2006-05-01	Method for preventing or treating respiratory infections and acute otitis media in infants
DE60307860D1 (de)	2006-10-05	Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
DE69831816D1 (de)	2006-02-16	Bakterizide desinfizierende peressigsäure-zusammensetzung
PL1633376T3 (pl)	2008-10-31	Środki do profilaktyki i leczenia objawów przeziębienia i grypopodobnych zawierające chelatowany cynk
EP1560821B8 (de)	2010-05-19	Antibakterielle wirkstoffe
YU102503A (sh)	2006-08-17	Kondenzovani pirimidinski dhfr inhibitori kao antibakterijska sredstva
WO2003032985A3 (en)	2003-11-06	Concomitant oral and topical administration of anti - infective agents
ES2133722T3 (es)	1999-09-16	Utilizacion de dextranos simples o conjugados para la fabricacion de un medicamento para prevenir o reducir el riesgo de infeccion de germenes patogenos bacterianos.
WO2006033713A3 (en)	2006-08-24	Methods for ciprofloxacin inhalation
DK1157688T3 (da)	2003-08-25	Antibakterielle vandige ophthalmiske formuleringer med ofloxacin og chitosan
WO2018107020A8 (en)	2018-09-07	Aminoglycoside potentiation for treatment of pulmonary bacterial infection
MY129637A (en)	2007-04-30	Use of bismuth subgallate in inhibition of production of nitric oxide synthase.
TW200503734A (en)	2005-02-01	New use of soluble p-selectin and anthrax lethal toxin
RU2006142517A (ru)	2008-06-10	Стекло